| Integrated Care Models | |
| Gave tax credit and exclusivity to companies who provided products for diseases that affect less than 200,000 people. | |
| Required that biologics be approved for purity, potency and safety. | |
| Requirements for drugs to demonstrate safety prior to release. Defined food, drugs, dietary and devices for animals and human use, and cosmetics only for human use. |